Professor David Henshall and colleagues from RCSI have published new findings identifying a potential disease-modifying drug for epilepsy. Currently, no epilepsy drug offers "disease modifying" effects, meaning that if a patient stops taking the drug their seizures will return.
Last Wednesdays Seminar " Its Good to Talk" on Epilepsy was very well attended by people travelling from All over the Midlands to the Tullamore Court Hotel.
New UK guidelines produced by the Royal College of Obstetricians and Gynaecologists, recommend women seek advice well before pregnancy on their care.
Medtronic plc, a medical device company based in Dublin, announced on Friday that the US Food and Drug Administration (FDA) has approved the testing of its Visualase(TM) laser ablation system in a clinical trial.
Sleep and rest are important for everyone, without it the risk of a range of health issues, including heart disease, stroke, depression, diabetes, hypertension, and cancer rise.
Epilepsy Ireland's patron Rick O'Shea was interviewed by Derek Carter, HODcast host about himself, his experience of Dublin and living with epilepsy.
Sanofi and the HPRA have updated & redistributed important information booklets on the use of valproate (e.g. Epilim) in women and the risks associated with the drug in pregnancy.
Epilepsy Ireland is holding its National Conference on Friday 7th & Saturday 8th October in Alexander Hotel, Dublin.
A new study conducted by Sungkyunkwan University School of Medicine, in Seoul, has shown a link between headaches and mood problems in people with epilepsy.
On Friday 15th July, the UCD Centre for Disability Studies will host a workshop entitled "Epilepsy and Intellectual Disability; Reducing risk, improving quality of life" for healthcare professionals and families.